Page last updated: 2024-12-11

ethyl caffeate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

(E)-ethyl 3-(3,4-dihydroxyphenyl)prop-2-enoate: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ethyl trans-caffeate : An ethyl ester resulting from the formal condensation of the carboxy group of trans-caffeic acid with ethanol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5317238
CHEMBL ID17347
CHEBI ID132714
CHEBI ID69656
SCHEMBL ID782032
MeSH IDM0102003

Synonyms (51)

Synonym
(e)-3-(3,4-dihydroxy-phenyl)-acrylic acid ethyl ester
bdbm50029196
3-(3,4-dihydroxy-phenyl)-acrylic acid ethyl ester
ethyl 1-(3'',4''-dihydroxyphenyl)propenate
ethyl 3-(3,4-dihydroxyphenyl)acrylate
nsc-619661
nsc619661
ethyl 3,4-dihydroxycinnamate
ethyl (e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
ethyl caffeate
CHEBI:132714
(e)-ethyl caffeate
ethyl trans-caffeate
ethyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
(e)-ethyl 3,4-dihydroxycinnamate
(e)-ethyl 3-(3,4-dihydroxyphenyl)acrylate
ethyl (2e)-3-(3,4-dihydroxyphenyl)acrylate
102-37-4
ethyl 3-(3,4-dihydroxyphenyl)prop-2-enoate
ethyl 1-(3',4'-dihydroxyphenyl)propenate
CHEMBL17347 ,
chebi:69656 ,
AKOS005167063
66648-50-8
2-propenoic acid, 3-(3,4-dihydroxyphenyl)-, ethyl ester
unii-76gbb1ju5y
76gbb1ju5y ,
caffeic acid ethyl ester
3,4-dihydroxycinnamic acid ethyl ester
ethyl caffeate [inci]
AKOS025310508
4GQQ
SCHEMBL782032
AC-34380
ethyl 3,4-dihydroxycinnamate, aldrichcpr
mfcd00045754
AS-69825
ethyl (e)-3-(3,4-dihydroxyphenyl)acrylate
DTXSID70876375
Q5404446
(e)-ethyl dihydroxycinnamate
AS-18100
CCG-266637
ethyl 3-(3,4-dihydroxyphenyl)-2-propenoate
(e)-ethyl 3-(3,4-dihydroxyphenyl)prop-2-enoate
HY-N6966
CS-W019100
caee
S5640
CS-0181967
HY-N6966A

Research Excerpts

Overview

Ethyl caffeate (EC) is a phenylpropanoid compound derived from Elephantopus scaber. EC is present in several medicinal plants used to treat inflammatory disorders.

ExcerptReferenceRelevance
"Ethyl caffeate (EC) is a natural phenolic compound that is present in several medicinal plants used to treat inflammatory disorders. "( Ethyl Caffeate Can Inhibit Aryl Hydrocarbon Receptor (AhR) Signaling and AhR-Mediated Potentiation of Mast Cell Activation.
Ishimaru, K; Kobayashi, Y; Nakamura, Y; Nakano, N; Nakao, A; Nguyen, PT; Nguyen, TA; Okuda, T; Tran, NQV; Watanabe-Saito, F, 2023
)
3.8
"Ethyl caffeate (EC) is a phenylpropanoid compound derived from Elephantopus scaber. "( Ethyl caffeate combined with fluconazole exhibits efficacy against azole-resistant oropharyngeal candidiasis via the EFGR/JNK/c-JUN signaling pathway.
Bao, M; Bu, Q; Li, N; Pan, M; Shao, J; Wang, C; Wang, T; Yang, R; Yang, Y, 2023
)
3.8

Toxicity

ExcerptReferenceRelevance
" Amyloid-beta42 protein (Aβ42), the most toxic and aggressive Aβ species, is the main focus of this study."( Ethyl caffeate ameliorated amyloid-beta42 protein-associated toxicity in PC12 cells and Drosophila melanogaster.
Azzam, G; Hadri, NAB; Najimudin, N; Tan, FHP; Watanabe, N, 2021
)
2.06

Compound-Compound Interactions

ExcerptReferenceRelevance
" In our previous work, EC was investigated to have a strong synergistic antifungal effect against azole-resistant strains of Candida albicans when combined with fluconazole (FLU)."( Ethyl caffeate combined with fluconazole exhibits efficacy against azole-resistant oropharyngeal candidiasis via the EFGR/JNK/c-JUN signaling pathway.
Bao, M; Bu, Q; Li, N; Pan, M; Shao, J; Wang, C; Wang, T; Yang, R; Yang, Y, 2023
)
2.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
anti-inflammatory agentAny compound that has anti-inflammatory effects.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
alkyl caffeate esterA cinnamate ester obtained by formal condensation of caffeic acid with any alkyl alcohol.
ethyl esterAny carboxylic ester resulting from the formal condensation of the carboxy group of a carboxylic acid with ethanol.
hydroxycinnamic acidAny member of the class of cinnamic acids carrying one or more hydroxy substituents.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Pancreatic alpha-amylaseHomo sapiens (human)Ki1,300.0000110.0000705.00001,300.0000AID977610
Chain A, Pancreatic alpha-amylaseHomo sapiens (human)Ki1,300.0000110.0000705.00001,300.0000AID977610
Integrase Human immunodeficiency virus 1IC50 (µMol)100.00000.00051.544310.0000AID371216; AID91430; AID91579
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
TransthyretinHomo sapiens (human)EC50 (µMol)23.00005.60007.54298.6000AID1169291
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (2)

Processvia Protein(s)Taxonomy
signal transductionTransthyretinHomo sapiens (human)
purine nucleobase metabolic processTransthyretinHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (4)

Processvia Protein(s)Taxonomy
hormone activityTransthyretinHomo sapiens (human)
protein bindingTransthyretinHomo sapiens (human)
identical protein bindingTransthyretinHomo sapiens (human)
thyroid hormone bindingTransthyretinHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
extracellular regionTransthyretinHomo sapiens (human)
extracellular spaceTransthyretinHomo sapiens (human)
azurophil granule lumenTransthyretinHomo sapiens (human)
extracellular exosomeTransthyretinHomo sapiens (human)
extracellular spaceTransthyretinHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (73)

Assay IDTitleYearJournalArticle
AID780242Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 24 hrs by WST-1 assay2013Bioorganic & medicinal chemistry, Nov-15, Volume: 21, Issue:22
Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.
AID684444Cytotoxicity against human NCI-H1299 cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID1235012Antiinflammatory activity in C57BL6/J mouse BV2 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay2015Journal of natural products, Jul-24, Volume: 78, Issue:7
Bioactive Sesquiterpenes and Lignans from the Fruits of Xanthium sibiricum.
AID1161633Antitumor activity against human HeLa cells assessed as inhibition of cell growth by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis and antitumor activity of feruloyl and caffeoyl derivatives.
AID1235018Cytotoxicity against MDCK cells assessed as growth inhibition by CPE assay2015Journal of natural products, Jul-24, Volume: 78, Issue:7
Bioactive Sesquiterpenes and Lignans from the Fruits of Xanthium sibiricum.
AID1169299Competitive binding to TTR V30M mutant (unknown origin) expressed in Escherichia coli at 1 to 80 uM by fluorescence assay2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretin.
AID8620Inhibitory concentration required against A 431 human epidermoid carcinoma cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID1426518Antinociceptive activity in CD1 mouse assessed as increase in thermal-stimulus induced paw withdrawal latency at 60 mg/kg, sc measured after 30 mins by hot plate method relative to control2017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Development of the First Two-Pore Domain Potassium Channel TWIK-Related K
AID1169294Inhibition of TTR V30M mutant (unknown origin) expressed in Escherichia coli assessed as inhibition of amyloid fibril formation at 20 uM by fluorescence assay2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretin.
AID1426515Antinociceptive activity in CD1 mouse assessed as inhibition of acetic acid-induced writhes at 10 mg/kg, sc pretreated for 15 mins followed by acetic acid challenge measured within 20 mins relative to control2017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Development of the First Two-Pore Domain Potassium Channel TWIK-Related K
AID1076849Inhibition of biofilm formation of Candida albicans ATCC 10231 by XTT reduction assay2014Bioorganic & medicinal chemistry letters, Mar-15, Volume: 24, Issue:6
Activity of caffeic acid derivatives against Candida albicans biofilm.
AID1179762Ratio of compound IC50 to trolox IC50 for ABTS radical scavenging activity after 12 hrs by spectrophotometry2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Phenylpropanoid acid esters from Korean propolis and their antioxidant activities.
AID1542227Inhibition of synthetic AcPHF6 peptide aggregation in pH 7.4 phosphate buffer assessed as reduction in fluorescence intensity at 50 uM and measured every minute over 2 hrs with 5 secs shaking prior to each reading by ThT fluorescence assay2019European journal of medicinal chemistry, Apr-01, Volume: 167Repurposing nitrocatechols: 5-Nitro-α-cyanocarboxamide derivatives of caffeic acid and caffeic acid phenethyl ester effectively inhibit aggregation of tau-derived hexapeptide AcPHF6.
AID39252Inhibitory concentration against B16 murine melanoma cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID1076845Cytotoxicity against human NCI-H292 cells assessed as reduction in viable cells by MTT assay2014Bioorganic & medicinal chemistry letters, Mar-15, Volume: 24, Issue:6
Activity of caffeic acid derivatives against Candida albicans biofilm.
AID449663Lipophilicity, log P of the compound2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Antinociceptive properties of caffeic acid derivatives in mice.
AID684445Cytotoxicity against human 292G cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID1235019Antiviral activity against Influenza A virus (A/FM/1/47(H1N1)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect2015Journal of natural products, Jul-24, Volume: 78, Issue:7
Bioactive Sesquiterpenes and Lignans from the Fruits of Xanthium sibiricum.
AID684442Cytotoxicity against human H266 cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID1076848Antifungal activity against early stage preformed Candida albicans ATCC 10231 biofilm by XTT reduction assay2014Bioorganic & medicinal chemistry letters, Mar-15, Volume: 24, Issue:6
Activity of caffeic acid derivatives against Candida albicans biofilm.
AID80256Inhibitory concentration against HCT 116 human colon cancer cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID362056Cytotoxicity against mouse RAW264.7 cells assessed as cell survival after 24 hrs by MTT assay2008Bioorganic & medicinal chemistry, Aug-15, Volume: 16, Issue:16
Inhibitory effect of the alkyl side chain of caffeic acid analogues on lipopolysaccharide-induced nitric oxide production in RAW264.7 macrophages.
AID1179758Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometry2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Phenylpropanoid acid esters from Korean propolis and their antioxidant activities.
AID736486Antioxidant activity assessed as inhibition of ABTS radical formation for 15 mins by spectrophotometric analysis2013European journal of medicinal chemistry, Apr, Volume: 62Exploring nature profits: development of novel and potent lipophilic antioxidants based on galloyl-cinnamic hybrids.
AID1076847Antifungal activity against mature preformed Candida albicans ATCC 10231 biofilm by XTT reduction assay2014Bioorganic & medicinal chemistry letters, Mar-15, Volume: 24, Issue:6
Activity of caffeic acid derivatives against Candida albicans biofilm.
AID736487Antioxidant activity assessed as inhibition of DPPH radical formation measured every min for 45 mins by spectrophotometric analysis2013European journal of medicinal chemistry, Apr, Volume: 62Exploring nature profits: development of novel and potent lipophilic antioxidants based on galloyl-cinnamic hybrids.
AID216250In vitro inhibitory activity against the growth of WISH cell derived from human cervical carcinoma was determined2004Bioorganic & medicinal chemistry letters, Jan-05, Volume: 14, Issue:1
Antiproliferative activity of various flavonoids and related compounds: additive effect of interferon-alpha2b.
AID684447Cytotoxicity against human LOXIMVI cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID684450Cytotoxicity against human M4E cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID362057Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells assessed as nitrite accumulation administered 1 hr before LPS challenge and measured after 24 hrs by Griess reagent assay2008Bioorganic & medicinal chemistry, Aug-15, Volume: 16, Issue:16
Inhibitory effect of the alkyl side chain of caffeic acid analogues on lipopolysaccharide-induced nitric oxide production in RAW264.7 macrophages.
AID684439Cytotoxicity against human NCI-H157 cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID1076846Antifungal activity against planktonically grown Candida albicans ATCC 10231 by CLSI M27 A3 broth microdilution method2014Bioorganic & medicinal chemistry letters, Mar-15, Volume: 24, Issue:6
Activity of caffeic acid derivatives against Candida albicans biofilm.
AID1161634Antitumor activity against human SiHa cells assessed as inhibition of cell growth by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis and antitumor activity of feruloyl and caffeoyl derivatives.
AID1161635Antitumor activity against human Bewo cells assessed as inhibition of cell growth by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis and antitumor activity of feruloyl and caffeoyl derivatives.
AID1179763Ratio of compound IC50 to trolox IC50 for DPPH radical scavenging activity after 30 mins by spectrophotometry2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Phenylpropanoid acid esters from Korean propolis and their antioxidant activities.
AID1617647Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as decrease in PGE2 production preincubated for 1 hr followed by LPS stimulation and measured after 24 hrs by ELISA
AID684451Cytotoxicity against human SKBR cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID684443Cytotoxicity against human HOP62 cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID1161636Antitumor activity against human HL60 cells assessed as inhibition of cell growth by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis and antitumor activity of feruloyl and caffeoyl derivatives.
AID684441Cytotoxicity against human NCI-H1792 cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID397183DPPH radical scavenging activity assessed as Trolox equivalent antioxidant capacity at 50 uM after 40 mins2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
New insights into the antioxidant activity of hydroxycinnamic acids: Synthesis and physicochemical characterization of novel halogenated derivatives.
AID684448Cytotoxicity against human M14 cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID1179760Antioxidant activity assessed as hydroxyl radical scavenging activity at 50 uM after 30 mins by Fenton reaction-induced DNA single strand breakage method2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Phenylpropanoid acid esters from Korean propolis and their antioxidant activities.
AID1235015Antiviral activity against Coxsackievirus B3 infected in African green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect2015Journal of natural products, Jul-24, Volume: 78, Issue:7
Bioactive Sesquiterpenes and Lignans from the Fruits of Xanthium sibiricum.
AID684440Cytotoxicity against human H460 cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID1183624Hypoglycemic activity in mouse 3T3L1 cells assessed as increase in glucose consumption at 50 ug/ml after 24 hrs by 2-deoxyglucose uptake assay2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Bioactive constituents of Cirsium japonicum var. australe.
AID750756Antagonist activity at Gloeobacter violaceus ligand-gated ion channel expressed in Xenopus oocytes assessed as inhibition of MES buffer pH 5.5 -induced currents after 30 secs by voltage clamp technique2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Identification of cinnamic acid derivatives as novel antagonists of the prokaryotic proton-gated ion channel GLIC.
AID780231Antiproliferative activity against human LNCAP cells at 1 to 10 uM after 72 hrs in presence of DHT2013Bioorganic & medicinal chemistry, Nov-15, Volume: 21, Issue:22
Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.
AID371216Inhibition of HIV1 integrase by ELISA2008Bioorganic & medicinal chemistry letters, Dec-15, Volume: 18, Issue:24
Synthesis of trans-caffeate analogues and their bioactivities against HIV-1 integrase and cancer cell lines.
AID1235020Selectivity index, ratio of TC50 for MDCK cells to IC50 for Influenza A virus (A/FM/1/47(H1N1))-induced cytopathic effect in MDCK cells2015Journal of natural products, Jul-24, Volume: 78, Issue:7
Bioactive Sesquiterpenes and Lignans from the Fruits of Xanthium sibiricum.
AID362058Ratio of EC50 for mouse RAW264.7 cells to EC50 for inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells2008Bioorganic & medicinal chemistry, Aug-15, Volume: 16, Issue:16
Inhibitory effect of the alkyl side chain of caffeic acid analogues on lipopolysaccharide-induced nitric oxide production in RAW264.7 macrophages.
AID1183627Antioxidant activity assessed as DPPH radical scavenging activity2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Bioactive constituents of Cirsium japonicum var. australe.
AID91579Inhibitory activity against HIV-1 Integrase (HIV-1-IN)2002Journal of medicinal chemistry, Feb-14, Volume: 45, Issue:4
CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
AID684446Cytotoxicity against human Calu1 cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID750755Inhibition of Gloeobacter violaceus ligand-gated ion channel expressed in Xenopus laevis oocytes assessed as inhibition of MES buffer pH 5.5 -induced currents at 1 mM after 30 secs by voltage clamp technique2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Identification of cinnamic acid derivatives as novel antagonists of the prokaryotic proton-gated ion channel GLIC.
AID397184ABTS radical scavenging activity assessed as Trolox equivalent antioxidant capacity at 50 uM by spectrophotometric analysis2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
New insights into the antioxidant activity of hydroxycinnamic acids: Synthesis and physicochemical characterization of novel halogenated derivatives.
AID397185Octanol-water partition coefficient, log P of the compound2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
New insights into the antioxidant activity of hydroxycinnamic acids: Synthesis and physicochemical characterization of novel halogenated derivatives.
AID1426519Antinociceptive activity in CD1 mouse assessed as increase in thermal-stimulus induced paw withdrawal latency at 60 mg/kg, sc measured after 45 mins by hot plate method relative to control2017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Development of the First Two-Pore Domain Potassium Channel TWIK-Related K
AID1161638Antitumor activity against human HepG2 cells assessed as inhibition of cell growth by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis and antitumor activity of feruloyl and caffeoyl derivatives.
AID467249Cytotoxicity against human HepG2 cells by SRB assay2009Journal of natural products, Jun, Volume: 72, Issue:6
Chemical constituents from the aerial parts of Artemisia minor.
AID1161637Antitumor activity against human SGC7901 cells assessed as inhibition of cell growth by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis and antitumor activity of feruloyl and caffeoyl derivatives.
AID1426512Agonist activity at human TREK1 expressed in xenopus oocytes assessed as increase in K+ current at 20 uM measured at 0 mV by double microelectrode method relative to control2017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Development of the First Two-Pore Domain Potassium Channel TWIK-Related K
AID1179757Antioxidant activity assessed as ABTS radical scavenging activity after 12 hrs by spectrophotometry2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Phenylpropanoid acid esters from Korean propolis and their antioxidant activities.
AID1698073Neuroprotective activity against glutamate-induced cell death in mouse HT-22 cells assessed as increase in cell viability after 24 hrs by EZ-Cytox assay
AID684449Cytotoxicity against human HeLa cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID91430In vitro inhibitory activity against HIV-1 integrase.1995Journal of medicinal chemistry, Oct-13, Volume: 38, Issue:21
Hydroxylated aromatic inhibitors of HIV-1 integrase.
AID1183628Antioxidant activity assessed as ABTS radical scavenging activity2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Bioactive constituents of Cirsium japonicum var. australe.
AID449642Antinociceptive activity in Swiss mouse by inhibition of acetic acid-induced abdominal constriction at 10 mg/kg, ip after 20 mins2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Antinociceptive properties of caffeic acid derivatives in mice.
AID684438Cytotoxicity against human A549 cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID1169300Displacement of ANS from TTR V30M mutant (unknown origin) expressed in Escherichia coli at 1 to 50 uM after 5 mins by fluorescence assay2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretin.
AID780232Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometry2013Bioorganic & medicinal chemistry, Nov-15, Volume: 21, Issue:22
Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.
AID1169291Inhibition of TTR V30M mutant (unknown origin) expressed in Escherichia coli assessed as inhibition of amyloid fibril formation by fluorescence assay2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretin.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2012Journal of medicinal chemistry, Nov-26, Volume: 55, Issue:22
Order and disorder: differential structural impacts of myricetin and ethyl caffeate on human amylase, an antidiabetic target.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (59)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.69)18.7374
1990's2 (3.39)18.2507
2000's18 (30.51)29.6817
2010's30 (50.85)24.3611
2020's8 (13.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.78 (24.57)
Research Supply Index4.09 (2.92)
Research Growth Index5.54 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other59 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]